Gamma delta (γδ) T cells are a type of innate-like T cell that possess dual anti-tumor activities, capable of directly eliminating tumor cells and acting as immunostimulatory cells to enhance the body’sRead More…
Review of Vaccine Adjuvant
Vaccination is undoubtedly one of the most remarkable health achievements in human history. In just over two centuries, vaccines have enabled us to achieve extraordinary goals, such as eradicating smallpox, eradicating polioRead More…
ACS Nano: Toll-Like Receptor 9 Agonist Boosts COVID-19 Vaccine
The development of effective vaccines for infectious diseases is one of the most successful global health interventions ever. Although subunit vaccines largely depend on the selection of antigens and adjuvants, the exposureRead More…
Tumor Vaccine Enhancement Progress Revealed: What’s the Highlight?
The trend in the field of cancer immunotherapy is the use of cancer vaccines. By using identified tumor antigens to stimulate the immune system, cancer vaccines can generate a specific immune responseRead More…
Progress in Research on Nipah Virus Vaccine
Recently, researchers from the Wuhan Institute of Virology, Chinese Academy of Sciences, published a research paper titled “Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection” in npjRead More…
Front Immunol: The Immune Response Stimulated by Conventional Vaccines May Potentially Aid in The Defense Against Various Types of Human Cancer
Nowadays, immunotherapy has shown great potential in treating human cancer, but it is not effective for all tumor types and only works for less than 3% of pancreatic ductal adenocarcinoma (PDAC) patients.Read More…
Oncolytic Virus Enlisted as a Helper to Hance DC Vaccine’s Anti-tumor Potency
Recently, a research paper titled “Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine” was published in Cell Reports Medicine, a sub-journal of Cell.Read More…
TLR9 Agonists Can Act as In-situ Anti-tumor Vaccines
Osteosarcoma (OS) is a highly malignant mesenchymal tumor composed of cells that produce bone-like and immature bone tissue. The peak incidence occurs in the second decade of life after birth. Although relativelyRead More…
An Alzheimer’s Disease Vaccine Targeting Senescence-associated Glycoproteins Has Been Developed
The American Heart Association’s Basic Cardiovascular Sciences Annual Conference in 2023, recently held in Boston, USA, featured a study indicating that a novel vaccine targeting inflammatory brain cells associated with Alzheimer’s diseaseRead More…
Cell: Novel Vaccine Technology Generates More Antibodies Against SARS-CoV-2 in Mice
In a recent study, the California Institute of Technology’s novel technology seeks to develop more effective vaccines, starting with SARS-CoV-2, the coronavirus that causes COVID-19. In mouse studies, this prototype vaccine producedRead More…